SCM
BBOT

Silverarc Capital Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Silverarc Capital Management’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$6.51M Hold
613,393
– – 1.2% 20
2025
Q1 		$6.93M Buy
613,393
+100,024
+19% +$1.13M 1.42% 23
2024
Q4 		$5.39M Hold
513,369
– – 1.18% 29
2024
Q3 		$5.36M Buy
513,369
+13,369
+3% +$140K 1.2% 29
2024
Q2 		$5.11M Hold
500,000
– – 1.21% 26
2024
Q1 		$5.2M Buy
+500,000
New +$5.2M 1.44% 25